LIVE
Home
Politics
Business
Opinion
Technology
Lifestyle
Entertainment
Video
Biogen heads for the worst day in a decade after ending trial for blockbuster Alzheimer's drug
Business
March 21, 2019
This article is being updated.
Previous article: Biogen shares plunge nearly 30% after ending trial for potential blockbuster Alzheimer's drug
Prev
Next article: Biogen posts its the worst day in 14 years after ending trial for blockbuster Alzheimer's drug
Next
via
CNBC
March 21st 2019
MixedTimes.com
Business
Biogen heads for the worst day in a decade after ending trial for blockbuster Alzheimer's drug
Home
Politics
Business
Opinion
Technology
Lifestyle
Entertainment
Video